Alnylam Pharmaceuticals
ALNY
#556
Rank
$43.93 B
Marketcap
$329.26
Share price
2.22%
Change (1 day)
37.19%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Quarterly Reports

Thumbnail Alnylam Pharmaceuticals
 Quarterly Report 2025-q3

Quarterly Report 2025-q3

Language: English

View Quarterly Report